Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Prevail Therapeutics Inc. | 0 | reported | 22 Jan 2021 | tx 10+375,793−4,358,486 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 Jan 2021 | TENDER | Prevail Therapeutics Inc. | 2,385,756 | — | |
| 22 Jan 2021 | OTHER | Prevail Therapeutics Inc. | 178,681 | 0.00 USD | deriv |
| 22 Jan 2021 | OTHER | Prevail Therapeutics Inc. | 1,329,219 | 0.00 USD | deriv |
| 22 Jan 2021 | OTHER | Prevail Therapeutics Inc. | 250,000 | 0.00 USD | deriv |
| 30 Dec 2020 | TAX_WITHHOLDING | Prevail Therapeutics Inc. | 89,037 | 23.02 USD | |
| 30 Dec 2020 | EXERCISE | Prevail Therapeutics Inc. | 120,537 | 10.26 USD | |
| 30 Dec 2020 | EXERCISE | Prevail Therapeutics Inc. | 5,256 | 0.18 USD | |
| 30 Dec 2020 | EXERCISE | Prevail Therapeutics Inc. | 5,256 | 0.00 USD | deriv |
| 30 Dec 2020 | EXERCISE | Prevail Therapeutics Inc. | 120,537 | 0.00 USD | deriv |
| 19 Feb 2020 | GRANT_AWARD | Prevail Therapeutics Inc. | 250,000 | 0.00 USD | deriv |